Showing results (2111-2120 of 2,240) with videos related to

Sort By:
Pageof 224
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140H L Parnes, C Cirrincione, J Aisner, et al.
Genomics|March 1, 1997
Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genesT Stankovic, P J Byrd, P R Cooper, et al.
Cancer|December 15, 1981
Intravenous vincristine infusion: phase I trialD V Jackson, V S Sethi, C L Spurr, et al.
The New Zealand Dental Journal|April 2, 2014
Ukaipō niho: the place of nurturing for oral healthJ R Broughton, M Person, J Te H Maipi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristicsA Schatzkin, E Lanza, L S Freedman, et al.
Genome Research|February 21, 1998
Contig maps and genomic sequencing identify candidate genes in the usher 1C locusM J Higgins, C D Day, N J Smilinich, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Genomics|August 1, 1997
A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 regionL H Reid, C Davies, P R Cooper, et al.
Rheumatology (Oxford, England)|November 16, 2001
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathiesF W Miller, L G Rider, Y L Chung, et al.
Pageof 224